Your browser doesn't support javascript.
loading
Aripiprazole in the treatment of acute episode of schizophrenia: a real-world study in China.
Li, Qian; Su, Yun'ai; Liao, Xuemei; Fang, Maosheng; Gao, Jianliang; Xu, Jia; Duan, Mingjun; Yu, Haiying; Yang, Yang; Chen, Zhiyu; Liu, Jintong; Yan, Shaoxiao; Yao, Peifen; Li, Shuying; Wang, Changhong; Wu, Bin; Zhang, Congpei; Si, Tianmei.
Affiliation
  • Li Q; Department of Psychopharmacology, Peking University Sixth Hospital (Institute of Mental Health), NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing 100191, China.
  • Su Y; Department of Psychopharmacology, Peking University Sixth Hospital (Institute of Mental Health), NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing 100191, China.
  • Liao X; Department of Psychopharmacology, Peking University Sixth Hospital (Institute of Mental Health), NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing 100191, China.
  • Fang M; Department of Psychiatry, Wuhan Mental Health Center, Wuhan, Hubei 430012, China.
  • Gao J; Department of Child and Adolescent Psychology, the Fourth People's Hospital of Hefei, Hefei, Anhui 230022, China.
  • Xu J; Mental Health Center, the First Psychiatric Hospital of Harbin, Harbin, Heilongjiang 150056, China.
  • Duan M; Department of Science and Education, the Fourth People's Hospital of Chengdu, Chengdu, Sichuan 610036, China.
  • Yu H; Department of Psychiatry, the Chinese People's Liberation Army 904th Hospital, Changzhou, Jiangsu 213003, China.
  • Yang Y; Department of Psychiatry, Beijing Anding Hospital, Beijing 100029, China.
  • Chen Z; Department of Psychiatry, Hangzhou Seventh People's Hospital, Hangzhou, Zhejiang 310063, China.
  • Liu J; Department of Adolescent and Child Psychological Behavior, Shandong Mental Health Center, Jinan, Shandong 250014, China.
  • Yan S; Department of Integrated Chinese and Western Medicine, Beijing Huilongguan Hospital, Beijing 102208, China.
  • Yao P; Department of Psychiatry, Shanghai Mental Health Center, Shanghai 201109, China.
  • Li S; Department of Psychiatry, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
  • Wang C; Department of Psychiatry, the Second Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan 456750, China.
  • Wu B; Department of Psychiatry, Xi'an Mental Health Center, Xi'an, Shaanxi 710067, China.
  • Zhang C; Mental Health Center, the First Psychiatric Hospital of Harbin, Harbin, Heilongjiang 150056, China.
  • Si T; Department of Psychopharmacology, Peking University Sixth Hospital (Institute of Mental Health), NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing 100191, China.
Chin Med J (Engl) ; 136(9): 1126-1128, 2023 05 05.
Article in En | MEDLINE | ID: mdl-37014776
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents Limits: Humans Country/Region as subject: Asia Language: En Journal: Chin Med J (Engl) Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents Limits: Humans Country/Region as subject: Asia Language: En Journal: Chin Med J (Engl) Year: 2023 Document type: Article